Enteropeptidase indirectly affects drug metabolism by regulating trypsin activation. Trypsin, in turn, activates other proteolytic enzymes, which can influence the breakdown of drug molecules. Disruptions in enteropeptidase activity may alter the pharmacokinetics of protein-based drugs or those requiring protein digestion for absorption, potentially leading to altered efficacy or adverse drug reactions.
